What is the Aviation Medication Transparency Act of 2026?

Photo by Roberto Sorin on Unsplash

Commercial airline pilots must be aware of which medications are permitted by the Federal Aviation Administration (FAA). In order to make it easier for pilots to track changes in this list, the US Senate has proposed and passed The Aviation Medication Transparency Act of 2026. This will help pilots track their medical needs without risking their pilot’s license.

What Does the Legislation Do?

Introduced as Senate Bill 3258 by Senators Tammy Duckworth (D-Ill.) and John Hoeven (R-N.D.), the bipartisan legislation passed the U.S. Senate on September 24, 2026. If signed into law, the FAA will be required to publish a public list of medications that are not permitted for pilots, air traffic controllers, and trainees.

The FAA will have to publish the list within one year of the bill’s passage, and they will be required to update it regularly. The list would identify approved prescription and over-the-counter medications, as well as medications requiring additional FAA review. Some drugs will receive a “Do Not Issue” or “Do Not Fly” designation, which is self-explanatory.

For medications that are only needed temporarily, the FAA will also have to explain the restrictions and non-working timelines for pilots on such drugs. The FAA will consult airline pilot labor organizations, doctors, and flight instructors when developing the list of approved medications.

Why Is This Important for Commercial Airline Pilots?

The FAA does already provide medication guidance to Aviation Medical Examiners, but pilots do not have quick and easy access to the information. The lack of transparency can give flight crew members uncertainty about their prescriptions, over-the-counter options, and potential treatments.

A pilot who takes a banned or restricted medication could lose their approval for medical certification complications and be prohibited from flying. This confusion could also discourage pilots from seeking out appropriate treatment. Information is key.

The Aviation Medication Transparency Act will hopefully result in more informed medical decisions for pilots and their providers. The bill should make these decisions easier to navigate, but it does not eliminate FAA medical requirements. Pilots should continue consulting their aviation medical examiner before starting, stopping, or changing medication.